Trimetazidine 60 mg Modified Release Tab Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Trimetazidine 60 mg Modified Release Tab Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Metabolic anti-anginal (modified release)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Trimetazidine 60 mg Modified Release Tab Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Trimetazidine 60 mg Modified Release Tab Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Trimetazidine 60 mg Modified Release Tab Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Trimetazidine 60 mg Modified Release Tab formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Chronic stable angina (refractory)
- Add-on anti-anginal therapy
- Angina with normal HR/BP on first-line therapy
Mechanism of Action
Trimetazidine inhibits 3-KAT, shifting cardiac metabolism from fatty-acid to glucose oxidation — more O2-efficient ATP production in ischaemic myocardium without affecting HR, BP or contractility.
Dosage & Administration
- 1 tablet twice daily with meals
- Swallow whole
- Avoid in Parkinson's disease
Side Effects
- GI upset
- Headache
- Mild dizziness
- Parkinsonian symptoms (rare, reversible)
Contraindications
- Parkinson's disease
- Parkinsonian symptoms
- Severe renal impairment
Storage
Store below 25°C.
PCD Pharma Franchise for Trimetazidine 60 mg Modified Release Tab Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Trimetazidine 60 mg Modified Release Tab Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Trimetazidine 60 mg Modified Release Tab Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Trimetazidine 60 mg Modified Release Tab Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Trimetazidine 60 mg Modified Release Tab Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Trimetazidine 60 mg Modified Release Tab Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Trimetazidine 60 mg Modified Release Tab Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Trimetazidine 60 mg Modified Release Tab Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Trimetazidine 60 mg Modified Release Tab Tablet?
MRPs range from ₹1950 to ₹1950 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Trimetazidine 60 mg Modified Release Tab Tablet?